Adult Sickle Cell Provider
Inova Schar Adult Sickle Cell Center, Inova Fairfax Hospital
University of Virginia, School of Medicine Inova Campus
Falls Church, Virginia, United States
With a robust background as an MD/PhD specializing in hematopoiesis, immunology, and internal medicine, my career is dedicated to the advancement of sickle cell disease (SCD). This unique dual qualification has equipped me with a robust scientific and clinical foundation, essential for my roles as the Director of Clinical Research at Inova Adult Sickle Cell Center and an Assistant Professor of Medicine at the University of Virginia School of Medicine. Leveraging this expertise, I have significantly contributed to improved patient outcomes and expanded clinical capabilities at our center.The Inova Adult Sickle Cell Center has evolved into a thriving clinic with increased patient volume and improved patient outcomes, bolstered by dynamic research initiatives. I lead various research projects aimed at advancing SCD management, including roles as co-primary investigator in a large Phase II/III clinical trial, and as the primary investigator in an investigator-initiated trial with several studies pending site initiation. I have also initated several of our own clinical research efforts and focused on disseminating our findings through publications and academic conferences.
Beyond research, I am dedicated to educating healthcare professionals within the Inova system—comprising hospitalists, emergency room physicians, fellows and medical residents—on implementing standardized care for SCD. My engagement extends into the community where I work to raise awareness and advocate for SCD patients. I serve on the advisory board of a community based SCD organization and actively participate in town halls events to engage community members. I recently hosted our first in-person SCD town hall attended by over 200 stakeholders, including leading experts and government officials. I am currently also contributing to the development of metrics for grading SCD severity and consult with pharmaceutical companies focused on SCD research. My vision for the Inova Adult Sickle Cell Center is to provide comprehensive care, significantly contribute to the development of advanced therapies as well as clinical research in SCD, addressing the critical needs of our patients in Northern Virginia.
Disclosure information not submitted.
Extramedullary Hematopoiesis in SCD is More Prevalent Than Previously Recognized
Saturday, June 8, 2024
6:00 PM – 7:00 PM ET
Abstract Breakout Session I Clinical Trials
Sunday, June 9, 2024
1:15 PM – 2:45 PM ET
Hydroxyurea May Improve Sickle Cell Nephropathy in Adults with HbSS
Sunday, June 9, 2024
2:09 PM – 2:27 PM ET
Empowering Minds, Easing Pain: The Role of Talk Therapy in Sickle Cell Disease
Sunday, June 9, 2024
3:15 PM – 3:30 PM ET